Evidence-based nutritional and lifestyle strategies play a pivotal role to address key challenges around GLP-1 treatment of obesity, making clinicians more effective in advancing their patients' health
N Engl J Med 358:25602572 The Action to Control Cardiovascular Risk in Diabetes Study Group (2008) Effects of intensive glucose lowering in type 2 diabetes
Suspected adverse reactions should be reported via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)
It finally went away, but I felt very tired and sleepy after starting a GLP-1 medication
"The medication gets people started, but what happens between appointments matters enormously," said Dr
As of November 2025, there are 2,914 lawsuits consolidated in MDL 3094 in the Eastern District of Pennsylvania, with over 100 new actions filed in recent months